| Financial Year |
March 31 2023 |
| Monetary Funds |
360,750,479.06 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
236,521,313.42 |
| Accounts Receivable |
1,498,041,350.50 |
| Advances to Suppliers |
208,939,855.38 |
| Other Receivables |
27,792,145.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
650,494,001.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
41,401,287.22 |
| Total Current Assets |
3,263,678,112.82 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,514,860,089.04 |
| Under-construction Projects |
62,549,147.61 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
297,167,736.64 |
| R&D expenses |
283,018.87 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,124,350.02 |
| Deferred Income Tax Assets |
62,138,401.93 |
| Other Non-Current Assets |
50,558,606.25 |
| Sub-Total of Non-Current Assets |
2,013,904,707.72 |
| Total Assets |
5,277,582,820.54 |
| Short-Term Loans |
1,318,400,377.84 |
| Trading Financial liabilities |
-- |
| Notes Payable |
130,270,101.42 |
| Accounts Payable |
296,884,648.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
30,436,088.45 |
| Taxes Payable |
11,573,976.04 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
32,104,890.47 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
29,294,685.35 |
| Other Current Liabilities |
66,035,562.28 |
| Sub-Total of Current Liabilities |
1,974,676,339.48 |
| Long-term Loans |
196,094,684.93 |
| Bonds Payable |
747,690,695.44 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
5,000,000.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,095,260,260.96 |
| Total Liabilities |
3,069,936,600.44 |
| Paid-In Capital(Or Share Stock) |
232,770,515.00 |
| Capital Surplus |
1,036,383,536.30 |
| Surplus Reserve |
93,710,751.88 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
724,595,642.95 |
| Minority Stockholder's Interest |
-3,044,899.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,210,691,119.78 |
| Owner's Equity（Stockholder's Equity） |
2,207,646,220.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,277,582,820.54 |
